Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$23.8M
2 rounds on record
Latest round
$13.8M
Venture round · Jul 2024 · 2 yr ago
Team
51-200
employees, estimated range
Backers
1
iGan Partners
The money's age
Long since its last round
26 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
Funding rounds
RoundDateAmountInvestorsSource
Venture round Jul 2024 $13.8M — BetaKit
Series A Jul 2024 $10M — PRNewswire
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Hypervision SurgicalSeed $8.3M · 3 yr ago
Making surgeries more precise, safer and faster. Guiding the future of surgery using AI-powered hyperspectral imaging.
Traditional hyperspectral imaging solutions are difficult to use. They provide data that is hard to interpret and often non-actionable…
WyvernSeed $7M · 3 yr ago • 11-50 employees
Discover hyperspectral imaging and Earth observation data from Wyvern. Access research-grade satellite imagery that reveals the hidden…
LumeriaFounded 2026
Lumeria is an at-home skin tracker and longitudinal skin monitoring device that fuses the multispectral imaging clinics use with AI to…
PixxelSeries C $100M · this month • Founded 2019 • 51-200 employees
Pixxel builds hyperspectral imaging satellites and earth observation analytics. Its constellation captures hundreds of spectral bands for…
Hyperspectral satellite imagery for critical mineral exploration. Esper maps lithium, rare earths & alteration zones from orbit — faster…

Overview

RetiSpec is a medical imaging company using advanced AI for the detection of neurodegenerative diseases through hyperspectral imaging of the eye.

News

News BetaKit 2 years ago
RetiSpec secures $13.8 million to detect Alzheimer's early through retinal imaging
The round brings in Eli Lilly and Topcon Healthcare as strategic investors.
Read more
Report
Press release PRNewswire 2 years ago
RetiSpec Closes $10M USD to Advance Commercialization of its AI-Driven Eye Test for Detection of Alzheimer
/PRNewswire/ - RetiSpec Inc., an innovator in AI-driven eye diagnostics for brain health, announced the successful closing of its $10M USD Series A financing....
Read more
Report
Press release PRNewswire 2 years ago
RetiSpec,Topcon Healthcare, Inc. Announce Collaboration, Investment to Help Bring Eye-Based AI Diagnostic Tool to Market
/PRNewswire/ - RetiSpec, Inc., an innovator in AI-powered eye diagnostics for brain health, and Topcon Healthcare, Inc. a leading provider of medical devices...
Read more
Report
News bioworld.com 4 years ago
Retispec develops noninvasive early Alzheimer's diagnostic
As attention turns to new drugs that can address the growing burden of Alzheimer's disease (AD) in an aging global population, Retispec Inc. has developed a noninvasive test that may be able to detect early signs of the neurodegenerative disease decades b
Read more
Report
News BetaKit 8 years ago
RetiSpec leveraging University of Minnesota tech to detect earlier-stage Alzheimer's
The collaboration and licensing agreement will allow the company to further develop technology for early detection of Alzheimer's disease.
Read more
Report

Financials

Total raised
$23.8M
Latest round
Venture - Series Unknown
Funding rounds
2
Funding rounds
Round Announced Amount
Venture - Series Unknown 2024 $13.8M Details
Series A 2024 $10M Details